Ginkgo Bioworks (DNA) Misses Q3 EPS by 7c

Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $55.43 million versus the consensus estimate of $48.08 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Change in Nonfarm Payrolls (Sep) 29K vs 90K Expected, Unemployment Rate 4.2%
• Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation